Address
Arsenal Capital Partners
320 Park Avenue
30th Floor
New York, NY 10022
United States
Phone
Website
Recent investment activity
KANDO id: 24052
Corporate information
Registration country
Funds managed
| Fund | Type | Vintage | Currency | Committed capital |
|---|---|---|---|---|
| Arsenal Capital Fund V | Venture | 2019 | USD | 2,360,000,000 |
| Arsenal Capital Partners IV LP | Venture | 2016 | USD | 1,300,000,000 |
| Arsenal Capital Partners III LP | Venture | 2013 | USD | 875,000,000 |
| Arsenal Capital Partners II | Venture | 2006 | USD | 500,000,000 |
| Arsenal Capital Partners LP | Venture | 2003 | USD | 300,000,000 |
| Arsenal Capital Partners III-B LP |
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 23 of 23| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Charter Brokerage LLC | N/A | ||||
|
|
Diversified Global Graphics Group | N/A | ||||
|
|
FirstAgain LLC | N/A | ||||
|
|
FrontStream Payments Inc | N/A | ||||
|
|
Genovique Specialties Corp | N/A | ||||
|
|
IDQ Holdings Inc | N/A | ||||
|
|
Imds Inc | N/A | ||||
|
|
KGS-Alpha Capital Markets LP | N/A | ||||
|
|
Novolyte Technologies Inc | N/A | ||||
|
|
Para-Chem | N/A | ||||
|
|
Priority Solutions | N/A | ||||
|
|
Renaissance Mark Inc | N/A | ||||
|
|
Royal Adhesives & Sealants LLC | N/A | ||||
|
|
Scientific Protein Laboratories LLC | SPL has been a world leader in the development and cGMP-compliant manufacturing of pancreatic enzymes, heparin and its analogs for nearly 30 years. | N/A | |||
|
|
Sermatech International Inc | N/A | ||||
|
|
Source Refrigeration & HVAC Inc | N/A | ||||
|
|
TallyGenicom LP | N/A | ||||
|
|
Tempo Financial Holdings Corp | N/A | ||||
|
|
Velsicol Chemical Corp | N/A | ||||
|
|
Vertellus Specialties Inc | N/A | ||||
|
|
Breckenridge IS Inc | N/A | ||||
|
|
Kypha Inc | Venture | ||||
|
Kel-Tech Inc | Provider of specialty chemicals for onshore production, field stimulation, and drilling applications. | Acquisition Exited |
Team
Former team members
| Employee | Company | Position | ||
|---|---|---|---|---|
| Aaron Davenport | XCapital | |||
| James Marden | SK Capital Partners |